Hacking: Another year, another insulin pump maker outed on stage
Smiths Medical
MassDevice.com +3 | The top 3 med-tech stories for June 17, 2013
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
CareFusion may be weighing 2 very different deals
Is Smiths Medical on the auction block?
European engineering conglomerate Smiths Medical confirmed late last week that it had received an offer for its medical division, refusing to divulge any other details of the "early stage" discussions.
Groups purporting to have inside information about the talks have reported that Smiths Group has taken steps to align Smiths Medical as a stand-alone entity and that it may sell for more than $2.62 billion (£2 billion).
CardioFocus raises $11M in debt round | Wall Street Beat
CardioFocus added $11 million to its coffers in a round of debt financing from Oxford Finance and Silicon Valley Bank as it commercializes its HeartLight endoscopic ablation system overseas and winds up enrollment in a pivotal U.S. trial.
CardioFocus CRO Renny Clark said the funds will help the company prepare for its submission to the FDA for the HeartLight device, which combines an endoscope and a laser ablation device, according to a press release.
Smiths Medical’s recall gets FDA’s highest-risk label | MassDevice.com On Call
MASSDEVICE ON CALL — The FDA put its highest-risk stamp on Smiths Medical’s alarm cable recall, warning that a rare issue may cause patients harm or even death.
The BCI remote alarm cables are meant for use with Smiths Medical’s 9004 Capnocheck Capnography systems, transferring alarms from the system to a remote alarm system.
FDA clears Smiths Medical’s at-home ambulatory care unit
St. Paul, Minn,-based device maker Smiths Medical got the green-light from the FDA for its newest ambulatory infusion system, which has been approved for at-home use.
The Cadd-Solis VIP ambulatory infusion system integrates some of Smith Medical’s other products, including its infusion pump, medication-level monitoring system and medication reservoirs
Echo Therapeutics prices offering | Wall Street Beat
Echo Therapeutics (NSDQ:ECTE) priced its public stock offering at 75¢ per share, saying it expects to raise about $10 million in gross proceeds.
The 13.3 million-share offering includes a 45-day over-allotment option for bookrunner Aegis Capital for another 2 million shares.
Medical device makers ink interoperability pledge
Nine medical device companies ranging from industry titans to small-cap movers inked a pledge to make the data generated by their devices available to patients, in a move aimed at ridding the healthcare system of unnecessary deaths by 2020.
Smiths Medical touts Euro win for safety IV catheter
St. Paul, Minn.-based medical device company Smiths Medical received CE Mark approval for its Jelco IntuitIV safety IV catheter, an intravenous infusion device designed to help clinicians and healthcare workers reduce the risk of unintended needlestick injuries.
Medical device companies: Who’s hiring?
The economic recovery has been slow going in the U.S. as the housing market and persistently high unemployment have proven particularly stubborn.
That’s why we were surprised, after looking at the employment numbers in our MassDevice Big 100 database, to find that only 3 of the largest 15 med-tech makers wound up cutting their global workforces last year.
